|
HSP90B1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66444635851803E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.95152791096598E-12 |
| Normal-vs-Stage2 |
6.10899999999859E-05 |
| Normal-vs-Stage3 |
7.7715611723761E-16 |
| Normal-vs-Stage4 |
1.70174985214544E-12 |
| Stage1-vs-Stage2 |
1.640440E-01 |
| Stage1-vs-Stage3 |
1.031800E-02 |
| Stage1-vs-Stage4 |
8.903600E-03 |
| Stage2-vs-Stage3 |
1.639770E-03 |
| Stage2-vs-Stage4 |
1.823150E-03 |
| Stage3-vs-Stage4 |
5.901600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63524749297039E-12 |
| Normal-vs-AfricanAmerican |
1.823620E-04 |
| Normal-vs-Asian |
2.14028794687238E-12 |
| Caucasian-vs-AfricanAmerican |
7.046400E-01 |
| Caucasian-vs-Asian |
7.219800E-01 |
| AfricanAmerican-vs-Asian |
6.167200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.9968917892329E-12 |
| Normal-vs-Female |
1.66444635851803E-12 |
| Male-vs-Female |
5.824600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.27296001201694E-12 |
| Normal-vs-Age(41-60Yrs) |
4.28612700886788E-12 |
| Normal-vs-Age(61-80Yrs) |
2.40485409364055E-12 |
| Normal-vs-Age(81-100Yrs) |
3.989700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.288000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.421600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.416000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.126400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.310600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.159200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.62447832963153E-12 |
| Classical-VS-Follicular |
5.50179999999623E-05 |
| Classical-VS-Other |
9.039600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.0220491947498E-12 |
| Tall-VS-Other |
3.600500E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
1.981860E-02 |
| Follicular-VS-Normal |
1.774360E-02 |
| Other-VS-Normal |
1.234480E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.99170022088902E-10 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
7.70770000046994E-07 |
|
|
